Viewing Study NCT03187795

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:37 PM
Ignite Modification Date: 2026-02-22 @ 8:52 AM
Study NCT ID: NCT03187795
Status: UNKNOWN
Last Update Posted: 2019-12-17
First Post: 2017-06-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Mirabegron and Oxybutynin Safety and Efficacy Trial in Spinal Cord Injury
Sponsor: Kessler Foundation
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Spinal Cord Injuries View
None Urinary Bladder, Neurogenic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Spinal Cord Injuries View
None Randomized Controlled Trial View
None Neurogenic Bladder View
None Rehabilitation View